Gastrointestinal issues or general weakness: Persistent nausea, vomiting, or diarrhea should be managed first to prevent dehydration or kidney stress
Finding no such infirmity in the single judges order, the division bench dismissed the appeal
It was a new experience for me
In 2024 the Food and Drug Administration added cardiovascular risk as a reason to be prescribed the GLP-1 drug Wegovy, grounded in results from a major trial that showed fewer heart attacks, strokes, and cardiovascular deaths in adults with obesity or overweight and established heart disease
A clean safety profile across TRIUMPH-1 and TRIUMPH-3 would help Lilly file faster and would discourage the FDA from requesting additional studies
Scott Isaacs, president-elect of the American Association of Clinical Endocrinology, describes patients who lost significant weight on semaglutide while taking other medications that required dose adjustments they didn't know about